{"id":"https://openalex.org/W4396576676","doi":"https://doi.org/10.1158/2159-8290.25739155.v1","title":"Figure S1, Figure S2, Figure S3, Figure S4 from Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts","display_name":"Figure S1, Figure S2, Figure S3, Figure S4 from Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts","publication_year":2024,"publication_date":"2024-05-02","ids":{"openalex":"https://openalex.org/W4396576676","doi":"https://doi.org/10.1158/2159-8290.25739155.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2159-8290.25739155.v1","doi":"https://doi.org/10.1158/2159-8290.25739155.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.25739155.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2159-8290.25739155.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025584573","display_name":"Timothy P. DiPeri","orcid":"https://orcid.org/0000-0003-1190-1640","observed_orcids":["https://orcid.org/0000-0003-1190-1640"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy P. DiPeri","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1190-1640","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024886364","display_name":"Kurt W. Evans","orcid":"https://orcid.org/0009-0008-6823-6809","observed_orcids":["https://orcid.org/0009-0008-6823-6809"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kurt W. Evans","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-6823-6809","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043598133","display_name":"Bailiang Wang","orcid":"https://orcid.org/0009-0006-6851-5985","observed_orcids":["https://orcid.org/0009-0006-6851-5985"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bailiang Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-6851-5985","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090637113","display_name":"Ming Zhao","orcid":"https://orcid.org/0009-0005-9985-4448","observed_orcids":["https://orcid.org/0009-0005-9985-4448"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ming Zhao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-9985-4448","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045794188","display_name":"Argun Ak\u00e7akanat","orcid":"https://orcid.org/0000-0002-4012-9840","observed_orcids":["https://orcid.org/0000-0002-4012-9840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Argun Akcakanat","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4012-9840","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073222026","display_name":"Maria Gabriela Raso","orcid":"https://orcid.org/0000-0003-2105-5556","observed_orcids":["https://orcid.org/0000-0003-2105-5556"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Gabriela Raso","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2105-5556","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007131126","display_name":"Yasmeen Q. Rizvi","orcid":"https://orcid.org/0009-0000-2719-4093","observed_orcids":["https://orcid.org/0009-0000-2719-4093"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasmeen Q. Rizvi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-2719-4093","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076745893","display_name":"Xiaofeng Zheng","orcid":"https://orcid.org/0009-0007-2171-7210","observed_orcids":["https://orcid.org/0009-0007-2171-7210"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaofeng Zheng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-2171-7210","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014580278","display_name":"Anil Korkut","orcid":"https://orcid.org/0000-0001-8072-9026","observed_orcids":["https://orcid.org/0000-0001-8072-9026"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anil Korkut","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8072-9026","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081444321","display_name":"Kaushik Varadarajan","orcid":"https://orcid.org/0000-0002-4114-5498","observed_orcids":["https://orcid.org/0000-0002-4114-5498"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kaushik Varadarajan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4114-5498","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076924169","display_name":"Burak Uzunparmak","orcid":"https://orcid.org/0000-0002-9791-8904","observed_orcids":["https://orcid.org/0000-0002-9791-8904"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Burak Uzunparmak","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9791-8904","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113033878","display_name":"Ecaterina E Ileana Dumbrava","orcid":"https://orcid.org/0000-0002-1959-0536","observed_orcids":["https://orcid.org/0000-0002-1959-0536"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ecaterina E. Dumbrava","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1959-0536","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084349853","display_name":"Shubham Pant","orcid":"https://orcid.org/0000-0001-9281-480X","observed_orcids":["https://orcid.org/0000-0001-9281-480X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shubham Pant","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9281-480X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044064524","display_name":"Jaffer A. Ajani","orcid":"https://orcid.org/0000-0001-9946-0629","observed_orcids":["https://orcid.org/0000-0001-9946-0629"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jaffer A. Ajani","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9946-0629","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022876688","display_name":"Paula Raffin Pohlmann","orcid":"https://orcid.org/0000-0001-7914-5162","observed_orcids":["https://orcid.org/0000-0001-7914-5162"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paula R. Pohlmann","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7914-5162","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057357591","display_name":"Vanessa Behrana Jensen","orcid":"https://orcid.org/0000-0002-8415-8416","observed_orcids":["https://orcid.org/0000-0002-8415-8416"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Behrana Jensen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8415-8416","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054771911","display_name":"Milind M. Javle","orcid":"https://orcid.org/0000-0001-9158-0941","observed_orcids":["https://orcid.org/0000-0001-9158-0941"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Milind Javle","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9158-0941","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031165814","display_name":"Jordi Ahnert Rodon","orcid":"https://orcid.org/0000-0001-6467-3632","observed_orcids":["https://orcid.org/0000-0001-6467-3632","https://orcid.org/0000-0003-2234-5248"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jordi Rodon","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6467-3632","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5076426660","display_name":"Funda Meric\u2010Bernstam","orcid":"https://orcid.org/0000-0001-6816-6072","observed_orcids":["https://orcid.org/0000-0001-6816-6072"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Funda Meric-Bernstam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6816-6072","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.025100000202655792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zanidatamab","display_name":"zanidatamab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.7369999885559082},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.9319999814033508},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9639999866485596},{"id":"https://openalex.org/keywords/her2-status","display_name":"HER2 status","score":0.6700000166893005},{"id":"https://openalex.org/keywords/erbb2-amplification","display_name":"ERBB2 amplification","score":0.9599999785423279},{"id":"https://openalex.org/keywords/actionable-genomic-alterations","display_name":"actionable genomic alterations","score":0.8640000224113464},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.9660000205039978},{"id":"https://openalex.org/keywords/jq1","display_name":"JQ1","score":0.800000011920929},{"id":"https://openalex.org/keywords/bet-inhibitors","display_name":"BET inhibitors","score":0.9430000185966492},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7730000019073486},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8130000233650208}],"concepts":[{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.4533873498439789},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32830142974853516},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.16200107336044312},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.07824486494064331},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.05351287126541138}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2159-8290.25739155.v1","doi":"https://doi.org/10.1158/2159-8290.25739155.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.25739155.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/25739155","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Figure_S1_Figure_S2_Figure_S3_Figure_S4_from_Co-clinical_Trial_of_Novel_Bispecific_Anti-HER2_Antibody_Zanidatamab_in_Patient-Derived_Xenografts/25739155","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/2159-8290.25739155.v1","doi":"https://doi.org/10.1158/2159-8290.25739155.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.25739155.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"display_name":"Life below water","id":"https://metadata.un.org/sdg/14","score":0.5099999904632568}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389240075","https://openalex.org/W4396544214","https://openalex.org/W4391844345","https://openalex.org/W4396576651","https://openalex.org/W4406869413","https://openalex.org/W3178309154","https://openalex.org/W4310603551","https://openalex.org/W4412480377","https://openalex.org/W4220811973","https://openalex.org/W4324129029"],"abstract_inverted_index":{"Supplementary":[0,68,93,120],"Figure":[1,69,94,121],"1:":[2],"HER2":[3,11],"status":[4,20],"of":[5,126],"patients":[6,62],"and":[7,17,23,66,144],"corresponding":[8],"PDX":[9,54,84],"models.":[10],"expression":[12],"was":[13,116],"assessed":[14],"by":[15,21,87],"IHC":[16],"ERBB2":[18],"amplification":[19],"FISH":[22],"NGS.":[24],"FISH,":[25],"fluorescence":[26],"in":[27,44,74,81,128],"situ":[28],"hybridization;":[29],"HER2,":[30],"human":[31],"epidermal":[32],"growth":[33],"factor":[34],"receptor":[35],"2;":[36],"NGS,":[37],"next-generation":[38],"sequencing.":[39],"Alterations":[40],"represents":[41],"genomic":[42,47],"alterations":[43,73],"available":[45,60],"CLIA":[46,56],"testing":[48],"on":[49,91],"archival":[50],"patient":[51,75],"samples":[52],"(matching":[53],"hosts).":[55],"results":[57],"were":[58,102],"not":[59,146],"for":[61,109],"matching":[63],"PDX.003.025,":[64],"PDX.003.263,":[65],"PDX.003.230.":[67],"2:":[70],"Actionable":[71],"gene":[72],"biopsies":[76],"compared":[77],"to":[78],"the":[79,82],"alteration":[80],"resulting":[83],"as":[85,141],"determined":[86],"whole":[88],"exome":[89],"sequencing":[90],"both.":[92],"3:":[95],"Cell":[96],"viability":[97],"assay":[98],"with":[99,104,130,151],"crizotinib.":[100],"Cells":[101],"treated":[103],"crizotinib":[105],"at":[106],"serial":[107],"dilutions":[108],"72":[110],"hours.":[111],"Following":[112],"SRB":[113],"staining,":[114],"IC50":[115],"calculated":[117],"using":[118],"CalcuSyn.":[119],"4.":[122],"In":[123],"vivo":[124],"assessment":[125],"zanidatamab":[127],"combination":[129],"BET":[131],"inhibitor":[132],"JQ1.":[133],"50":[134],"mg/kg":[135,153],"JQ1":[136],"had":[137],"no":[138],"antitumor":[139],"effects":[140],"single":[142],"agent":[143],"did":[145],"add":[147],"benefit":[148],"when":[149],"combined":[150],"16":[152],"zanidatamab.":[154]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2024-05-03T00:00:00"}